1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
InvenTrust Properties Corp. signed a note purchase agreement on April 16, 2026, for a private placement of $250 million in senior notes in three series. The notes are expected to be issued on June 29, 2026, subject to customary closing conditions, and the company plans to use the proceeds for general corporate purposes, including repaying indebtedness. The deal adds fixed-rate debt that shareholders will carry until the notes mature in 2029, 2031 and 2033.
Total principal of $250 million: $50 million Series A at 5.09% due June 29, 2029; $100 million Series B at 5.32% due June 29, 2031; $100 million Series C at 5.60% due June 29, 2033
Press release states a weighted average fixed interest rate of 5.44% and a weighted average tenor of approximately 5.4 years
Expected issuance date is June 29, 2026, subject to customary closing conditions
Notes contain restrictive covenants, including leverage and coverage ratios, and can accelerate on certain defaults
PENN Entertainment amended its credit agreement on April 16, 2026, refinancing and extending its $1.0 billion revolving credit facility and $446.9 million term loan A facility, which now mature in April 2031. The filing does not report financial results, and the company's term loan B facility was not refinanced and keeps its existing maturity.
Revolver of $1.0 billion and term loan A of $446.9 million refinanced and extended under the amendment, maturing April 2031
Springing maturity 91 days inside certain existing debt obligations applies if that debt remains outstanding and is not refinanced, unless certain liquidity conditions are met
Amendment removed the 0.10% credit spread adjustment on SOFR borrowings; interest rate margins were otherwise unchanged
Term loan B facility was not refinanced and its maturity is unchanged; proceeds to refinance existing revolver and term loan A and fund working capital and general corporate purposes
Acurx Pharmaceuticals agreed on April 15, 2026 to sell about $2.5 million of common stock and pre-funded warrants in a registered direct offering at $3.03 per share, before placement agent fees and expenses. A concurrent private placement adds Series H warrants for 1,650,170 shares at $2.78 per share, which could bring up to about $4.6 million if fully exercised, so existing shareholders face dilution and the warrants are not assured to be exercised.
Registered offering: 816,068 common shares at $3.03 per share, plus pre-funded warrants for 9,017 shares at $3.029, for about $2.5 million gross before fees
Concurrent private placement: Series H warrants for 1,650,170 shares at $2.78 per share, exercisable immediately and expiring 24 months after the resale registration becomes effective
Placement agent H.C. Wainwright & Co. receives a cash fee of 6.0% of gross proceeds, plus up to $50,000 for legal fees and $15,950 for clearing expenses
Closing is expected on or about April 16, 2026; the company plans to use proceeds for working capital and general corporate purposes
On April 14, 2026, Lumen entered a Revolving Credit Agreement with Bank of America as administrative agent, providing $825 million of revolving commitments. The agreement also terminated the revolving commitments under a March 22, 2024 credit agreement, reducing them to zero.
Revolving commitments total $825 million; the facility matures April 14, 2029, subject to a springing maturity in certain circumstances.
Borrowings bear interest at Term SOFR (0.00% floor) plus 2.75%, or a base rate plus 1.75%, adjusted by Lumen's total net leverage ratio.
Covenants start with the quarter ended June 30, 2026: maximum total net leverage of 5.25 to 1.00 and minimum interest coverage of 2.00 to 1.00.
Level 3 Collateral Guarantors provide a guarantee of up to $150 million secured by substantially all of their assets.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.